ProCE Banner Series

Do It Better: Raising the Bar in Heart Failure Care With Practical Strategies for Treatment With SGLT2 Inhibitors

Join leading experts at this live satellite symposium at ACC.25, focusing on addressing clinical gaps in heart failure management, evaluating the benefits of SGLT2 inhibitors, and providing practical strategies for their integration into guideline-directed therapy to improve cardiovascular outcomes across the spectrum of left ventricular ejection fraction. Join us in-person or virtually.

This event is not part of ACC.25, as planned by its Program Committee, and does not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Who Should Attend

This educational program is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with heart failure.

All Events

Do It Better: Raising the Bar in Heart Failure Care With Practical Strategies for Treatment With SGLT2 Inhibitors

Upcoming Events

March

30

2025

5:45 AM - 7:45 AM Central Time (CT)

In-person

Hyatt Regency McCormick Place, 2233 S Martin Luther King Dr., Chicago, Illinois 60616

6:15 AM - 7:45 AM Central Time (CT)

Virtual

Topics

Heart failure

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Heart Failure.

Target Audience
This educational program is intended for cardiology physicians, nurse practitioners, and physician associates who care for patients with heart failure.

Learning Objectives.
Upon completion of this activity, participants should be able to:

  • Recognize clinical gaps in heart failure management and the importance of applying guideline-directed medical therapy
  • Evaluate the benefits and safety of early and sustained use of SGLT2 inhibitors in heart failure management and their impact on cardiovascular outcomes in eligible patients
  • Implement practical strategies for integrating SGLT2 inhibitors into treatment plans for eligible patients with heart failure across the spectrum of left ventricular ejection fraction

Accreditation

This educational activity is not certified for CME/CE credit.

Acknowledgement

Provided by Clinical Care Options, LLC.

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.